sotalol viatris (sotalol mylan) tafla 80 mg
viatris limited - sotalolum hýdróklóríð - tafla - 80 mg
apomorfin pharmswed innrennslislyf, lausn 5 mg/ml
evolan pharma ab - apomorphin hýdróklóríð - innrennslislyf, lausn - 5 mg/ml
noritren tafla 10 mg
h. lundbeck a/s* - nortriptylinum hýdróklóríð - tafla - 10 mg
noritren tafla 25 mg
h. lundbeck a/s* - nortriptylinum hýdróklóríð - tafla - 25 mg
noritren tafla 50 mg
h. lundbeck a/s* - nortriptylinum hýdróklóríð - tafla - 50 mg
xtandi
astellas pharma europe b.v. - enzalutamíð - blöðruhálskirtli - innkirtla meðferð - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
quetiapin medical valley forðatafla 300 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 300 mg
seroquel prolong forðatafla 50 mg
cheplapharm arzneimittel gmbh - quetiapinum fúmarat - forðatafla - 50 mg
seroquel prolong forðatafla 300 mg
cheplapharm arzneimittel gmbh - quetiapinum fúmarat - forðatafla - 300 mg
seroquel prolong forðatafla 200 mg
cheplapharm arzneimittel gmbh - quetiapinum fúmarat - forðatafla - 200 mg